Industry Research Reports

Home > Reports > Service & Software > Global Drug Repositioning Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Global Drug Repositioning Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Industry: Service & Software

Published Date: 2026-01-05

Pages: 96 Pages

Report ld: 5571592

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Industry Insights:

Drug Repositioning Research：CAGR of 4.7% during the forecast period

Drug Repositioning Market Size(US$)

CAGR 2026-2032

4.7%

Market Size,2032

USD 42,560

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 32,310 million

Market Forecast in 2032(Value)

US$ 42,560 million

CAGR

4.7%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Drug Repositioning market size was US$ 30990 million in 2025 and is forecast to reach a readjusted size of US$ 42560 million by 2032 with a CAGR of 4.7% during the forecast period 2026-2032.

Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.

The drug repositioning market is driven by the growing demand for cost-effective and time-saving drug development strategies. Traditional drug discovery can take over a decade and cost billions of dollars, with a high risk of failure during clinical trials. Repositioning, on the other hand, allows pharmaceutical companies to repurpose known drugs with existing safety and pharmacokinetic profiles, thereby accelerating time to market and reducing development risk. This approach is especially appealing for rare diseases, cancer, and neurodegenerative disorders where treatment options are limited. Additionally, advances in data mining, artificial intelligence, and systems biology have improved the ability to identify new drug-disease relationships, fueling further interest. Regulatory agencies such as the FDA and EMA also support repositioning by offering faster review pathways and incentives for orphan indications, making this strategy increasingly viable from a business perspective.

Despite its advantages, the drug repositioning market faces several challenges. One of the major issues is intellectual property protection—many repositioned drugs are off-patent, making it difficult for companies to secure exclusivity and justify investment. In cases where patent life can be extended through new formulations or uses, legal and regulatory hurdles still exist. Another challenge lies in clinical validation; while safety data may already be available, proving efficacy for a new indication still requires substantial clinical trial investment. Moreover, the lack of centralized, standardized databases for repositioning candidates limits discovery efficiency. The fragmented nature of available data—spread across academic publications, clinical trial registries, and real-world evidence—makes it hard to integrate and analyze comprehensively. Finally, collaboration between industry and academia, which is crucial for repositioning, is often hindered by misaligned goals and timelines.

The global Drug Repositioning market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.

MARKET SEGMENTATION

By Company

Teva
Novartis
Mylan
Johnson & Johnson
Pfizer
Bausch Health
GSK
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Generic Drugs
Clinical Trial Failed Drugs

Segment by Application

Cardiovascular Diseases
Mental Illness
Cancer
Others

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Drug Repositioning value chain, addressing:

- Market entry risks/opportunities by region

- Product mix optimization based on local practices

- Competitor tactics in fragmented vs. consolidated markets

biaoTi QYRESEARCH'S STRENGTHS

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032

1.2.2 Generic Drugs

1.2.3 Clinical Trial Failed Drugs

1.3 Market by Application

1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032

1.3.2 Cardiovascular Diseases

1.3.3 Mental Illness

1.3.4 Cancer

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Drug Repositioning Market Perspective (2021-2032)

2.2 Global Market Size by Region: 2021 vs 2025 vs 2032

2.3 Global Drug Repositioning Market Share by Revenue, by Region (2021-2026)

2.4 Global Drug Repositioning Revenue Forecast by Region (2027-2032)

2.5 Major Regions and Emerging Markets Analysis

2.5.1 North America Drug Repositioning Market Size and Prospective (2021-2032)

2.5.2 Europe Drug Repositioning Market Size and Prospective (2021-2032)

2.5.3 China Drug Repositioning Market Size and Prospective (2021-2032)

2.5.4 Japan Drug Repositioning Market Size and Prospective (2021-2032)

2.5.5 Southeast Aisa Drug Repositioning Market Size and Prospective (2021-2032)

2.5.6 India Drug Repositioning Market Size and Prospective (2021-2032)

3 Breakdown Data by Type

3.1 Global Drug Repositioning Historical Market Size by Type (2021-2026)

3.2 Global Drug Repositioning Forecasted Market Size by Type (2027-2032)

3.3 Representative Players for Different Types of Drug Repositioning

4 Breakdown Data by Application

4.1 Global Drug Repositioning Historical Market Size by Application (2021-2026)

4.2 Global Drug Repositioning Forecasted Market Size by Application (2027-2032)

4.3 New Sources of Growth in Drug Repositioning Applications

5 Competitive Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top Drug Repositioning Players by Revenue (2021-2026)

5.1.2 Global Drug Repositioning Market Share by Revenue, by Players (2021-2026)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by Drug Repositioning Revenue

5.4 Global Drug Repositioning Market Concentration Analysis

5.4.1 Global Drug Repositioning Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by Drug Repositioning Revenue in 2025

5.5 Global Key Players of Drug Repositioning Head Offices and Areas Served

5.6 Global Key Players of Drug Repositioning, Product and Application

5.7 Global Key Players of Drug Repositioning, Date of Entry into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Drug Repositioning Revenue by Company (2021-2026)

6.1.2 North America Market Size by Type

6.1.2.1 North America Drug Repositioning Market Size by Type (2021-2026)

6.1.2.2 North America Drug Repositioning Market Share by Type (2021-2026)

6.1.3 North America Market Size by Application

6.1.3.1 North America Drug Repositioning Market Size by Application (2021-2026)

6.1.3.2 North America Drug Repositioning Market Share by Application (2021-2026)

6.1.4 North America Drug Repositioning Major Customers

6.1.5 North America Market Trends and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Drug Repositioning Revenue by Company (2021-2026)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe Drug Repositioning Market Size by Type (2021-2026)

6.2.2.2 Europe Drug Repositioning Market Share by Type (2021-2026)

6.2.3 Europe Market Size by Application

6.2.3.1 Europe Drug Repositioning Market Size by Application (2021-2026)

6.2.3.2 Europe Drug Repositioning Market Share by Application (2021-2026)

6.2.4 Europe Drug Repositioning Major Customers

6.2.5 Europe Market Trends and Opportunities

6.3 China Market: Players, Segments, Downstream and Major Customers

6.3.1 China Drug Repositioning Revenue by Company (2021-2026)

6.3.2 China Market Size by Type

6.3.2.1 China Drug Repositioning Market Size by Type (2021-2026)

6.3.2.2 China Drug Repositioning Market Share by Type (2021-2026)

6.3.3 China Market Size by Application

6.3.3.1 China Drug Repositioning Market Size by Application (2021-2026)

6.3.3.2 China Drug Repositioning Market Share by Application (2021-2026)

6.3.4 China Drug Repositioning Major Customers

6.3.5 China Market Trends and Opportunities

6.4 Japan Market: Players, Segments, Downstream and Major Customers

6.4.1 Japan Drug Repositioning Revenue by Company (2021-2026)

6.4.2 Japan Market Size by Type

6.4.2.1 Japan Drug Repositioning Market Size by Type (2021-2026)

6.4.2.2 Japan Drug Repositioning Market Share by Type (2021-2026)

6.4.3 Japan Market Size by Application

6.4.3.1 Japan Drug Repositioning Market Size by Application (2021-2026)

6.4.3.2 Japan Drug Repositioning Market Share by Application (2021-2026)

6.4.4 Japan Drug Repositioning Major Customers

6.4.5 Japan Market Trends and Opportunities

6.5 Southeast Aisa Market: Players, Segments, Downstream and Major Customers

6.5.1 Southeast Aisa Drug Repositioning Revenue by Company (2021-2026)

6.5.2 Southeast Aisa Market Size by Type

6.5.2.1 Southeast Aisa Drug Repositioning Market Size by Type (2021-2026)

6.5.2.2 Southeast Aisa Drug Repositioning Market Share by Type (2021-2026)

6.5.3 Southeast Aisa Market Size by Application

6.5.3.1 Southeast Aisa Drug Repositioning Market Size by Application (2021-2026)

6.5.3.2 Southeast Aisa Drug Repositioning Market Share by Application (2021-2026)

6.5.4 Southeast Aisa Drug Repositioning Major Customers

6.5.5 Southeast Aisa Market Trends and Opportunities

6.6 India Market: Players, Segments, Downstream and Major Customers

6.6.1 India Drug Repositioning Revenue by Company (2021-2026)

6.6.2 India Market Size by Type

6.6.2.1 India Drug Repositioning Market Size by Type (2021-2026)

6.6.2.2 India Drug Repositioning Market Share by Type (2021-2026)

6.6.3 India Market Size by Application

6.6.3.1 India Drug Repositioning Market Size by Application (2021-2026)

6.6.3.2 India Drug Repositioning Market Share by Application (2021-2026)

6.6.4 India Drug Repositioning Major Customers

6.6.5 India Market Trends and Opportunities

7 Key Player Profiles

7.1 Teva

7.1.1 Teva Company Details

7.1.2 Teva Business Overview

7.1.3 Teva Drug Repositioning Introduction

7.1.4 Teva Revenue in Drug Repositioning Business (2021-2026)

7.1.5 Teva Recent Development

7.2 Novartis

7.2.1 Novartis Company Details

7.2.2 Novartis Business Overview

7.2.3 Novartis Drug Repositioning Introduction

7.2.4 Novartis Revenue in Drug Repositioning Business (2021-2026)

7.2.5 Novartis Recent Development

7.3 Mylan

7.3.1 Mylan Company Details

7.3.2 Mylan Business Overview

7.3.3 Mylan Drug Repositioning Introduction

7.3.4 Mylan Revenue in Drug Repositioning Business (2021-2026)

7.3.5 Mylan Recent Development

7.4 Johnson & Johnson

7.4.1 Johnson & Johnson Company Details

7.4.2 Johnson & Johnson Business Overview

7.4.3 Johnson & Johnson Drug Repositioning Introduction

7.4.4 Johnson & Johnson Revenue in Drug Repositioning Business (2021-2026)

7.4.5 Johnson & Johnson Recent Development

7.5 Pfizer

7.5.1 Pfizer Company Details

7.5.2 Pfizer Business Overview

7.5.3 Pfizer Drug Repositioning Introduction

7.5.4 Pfizer Revenue in Drug Repositioning Business (2021-2026)

7.5.5 Pfizer Recent Development

7.6 Bausch Health

7.6.1 Bausch Health Company Details

7.6.2 Bausch Health Business Overview

7.6.3 Bausch Health Drug Repositioning Introduction

7.6.4 Bausch Health Revenue in Drug Repositioning Business (2021-2026)

7.6.5 Bausch Health Recent Development

7.7 GSK

7.7.1 GSK Company Details

7.7.2 GSK Business Overview

7.7.3 GSK Drug Repositioning Introduction

7.7.4 GSK Revenue in Drug Repositioning Business (2021-2026)

7.7.5 GSK Recent Development

7.8 ChemRar Group

7.8.1 ChemRar Group Company Details

7.8.2 ChemRar Group Business Overview

7.8.3 ChemRar Group Drug Repositioning Introduction

7.8.4 ChemRar Group Revenue in Drug Repositioning Business (2021-2026)

7.8.5 ChemRar Group Recent Development

7.9 Glenmark

7.9.1 Glenmark Company Details

7.9.2 Glenmark Business Overview

7.9.3 Glenmark Drug Repositioning Introduction

7.9.4 Glenmark Revenue in Drug Repositioning Business (2021-2026)

7.9.5 Glenmark Recent Development

7.10 Fujifilm

7.10.1 Fujifilm Company Details

7.10.2 Fujifilm Business Overview

7.10.3 Fujifilm Drug Repositioning Introduction

7.10.4 Fujifilm Revenue in Drug Repositioning Business (2021-2026)

7.10.5 Fujifilm Recent Development

7.11 Dr. Reddy

7.11.1 Dr. Reddy Company Details

7.11.2 Dr. Reddy Business Overview

7.11.3 Dr. Reddy Drug Repositioning Introduction

7.11.4 Dr. Reddy Revenue in Drug Repositioning Business (2021-2026)

7.11.5 Dr. Reddy Recent Development

7.12 R-Pharma

7.12.1 R-Pharma Company Details

7.12.2 R-Pharma Business Overview

7.12.3 R-Pharma Drug Repositioning Introduction

7.12.4 R-Pharma Revenue in Drug Repositioning Business (2021-2026)

7.12.5 R-Pharma Recent Development

8 Drug Repositioning Market Dynamics

8.1 Drug Repositioning Industry Trends

8.2 Drug Repositioning Market Drivers

8.3 Drug Repositioning Market Challenges

8.4 Drug Repositioning Market Restraints

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Drug Repositioning Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Global Drug Repositioning Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 3. Global Market Drug Repositioning Market Size (US$ Million) by Region:2021 vs 2025 vs 2032

Table 4. Global Drug Repositioning Revenue (US$ Million) Market Share by Region (2021-2026)

Table 5. Global Drug Repositioning Revenue Share by Region (2021-2026)

Table 6. Global Drug Repositioning Revenue (US$ Million) Forecast by Region (2027-2032)

Table 7. Global Drug Repositioning Revenue Share Forecast by Region (2027-2032)

Table 8. Global Drug Repositioning Market Size by Type (2021-2026) & (US$ Million)

Table 9. Global Drug Repositioning Market Share by Revenue, by Type (2021-2026)

Table 10. Global Drug Repositioning Forecasted Market Size by Type (2027-2032) & (US$ Million)

Table 11. Global Drug Repositioning Market Share by Revenue, by Type (2027-2032)

Table 12. Representative Players of Each Type

Table 13. Global Drug Repositioning Market Size by Application (2021-2026) & (US$ Million)

Table 14. Global Drug Repositioning Market Share by Revenue, by Application (2021-2026)

Table 15. Global Drug Repositioning Forecasted Market Size by Application (2027-2032) & (US$ Million)

Table 16. Global Drug Repositioning Market Share by Revenue, by Application (2027-2032)

Table 17. New Sources of Growth in Drug Repositioning Applications

Table 18. Global Drug Repositioning Revenue by Players (2021-2026) & (US$ Million)

Table 19. Global Drug Repositioning Market Share by Players (2021-2026)

Table 20. Global Top Drug Repositioning Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Repositioning as of 2025)

Table 21. Ranking of Global Top Drug Repositioning Companies by Revenue (US$ Million) in 2025

Table 22. Global 5 Largest Players Market Share by Drug Repositioning Revenue (CR5 and HHI) & (2021-2026)

Table 23. Global Key Players of Drug Repositioning, Headquarters and Area Served

Table 24. Global Key Players of Drug Repositioning, Product and Application

Table 25. Global Key Players of Drug Repositioning, Date of Entry into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. North America Drug Repositioning Revenue by Company (2021-2026) & (US$ Million)

Table 28. North America Drug Repositioning Market Share by Revenue, by Company (2021-2026)

Table 29. North America Drug Repositioning Market Size by Type (2021-2026) & (US$ Million)

Table 30. North America Drug Repositioning Market Size by Application (2021-2026) & (US$ Million)

Table 31. Europe Drug Repositioning Revenue by Company (2021-2026) & (US$ Million)

Table 32. Europe Drug Repositioning Market Share by Revenue, by Company (2021-2026)

Table 33. Europe Drug Repositioning Market Size by Type (2021-2026) & (US$ Million)

Table 34. Europe Drug Repositioning Market Size by Application (2021-2026) & (US$ Million)

Table 35. China Drug Repositioning Revenue by Company (2021-2026) & (US$ Million)

Table 36. China Drug Repositioning Market Share by Revenue, by Company (2021-2026)

Table 37. China Drug Repositioning Market Size by Type (2021-2026) & (US$ Million)

Table 38. China Drug Repositioning Market Size by Application (2021-2026) & (US$ Million)

Table 39. Japan Drug Repositioning Revenue by Company (2021-2026) & (US$ Million)

Table 40. Japan Drug Repositioning Market Share by Revenue, by Company (2021-2026)

Table 41. Japan Drug Repositioning Market Size by Type (2021-2026) & (US$ Million)

Table 42. Japan Drug Repositioning Market Size by Application (2021-2026) & (US$ Million)

Table 43. Southeast Aisa Drug Repositioning Revenue by Company (2021-2026) & (US$ Million)

Table 44. Southeast Aisa Drug Repositioning Market Share by Revenue, by Company (2021-2026)

Table 45. Southeast Aisa Drug Repositioning Market Size by Type (2021-2026) & (US$ Million)

Table 46. Southeast Aisa Drug Repositioning Market Size by Application (2021-2026) & (US$ Million)

Table 47. India Drug Repositioning Revenue by Company (2021-2026) & (US$ Million)

Table 48. India Drug Repositioning Market Share by Revenue, by Company (2021-2026)

Table 49. India Drug Repositioning Market Size by Type (2021-2026) & (US$ Million)

Table 50. India Drug Repositioning Market Size by Application (2021-2026) & (US$ Million)

Table 51. Teva Company Details

Table 52. Teva Business Overview

Table 53. Teva Drug Repositioning Product

Table 54. Teva Revenue in Drug Repositioning Business (2021-2026) & (US$ Million)

Table 55. Teva Recent Development

Table 56. Novartis Company Details

Table 57. Novartis Business Overview

Table 58. Novartis Drug Repositioning Product

Table 59. Novartis Revenue in Drug Repositioning Business (2021-2026) & (US$ Million)

Table 60. Novartis Recent Development

Table 61. Mylan Company Details

Table 62. Mylan Business Overview

Table 63. Mylan Drug Repositioning Product

Table 64. Mylan Revenue in Drug Repositioning Business (2021-2026) & (US$ Million)

Table 65. Mylan Recent Development

Table 66. Johnson & Johnson Company Details

Table 67. Johnson & Johnson Business Overview

Table 68. Johnson & Johnson Drug Repositioning Product

Table 69. Johnson & Johnson Revenue in Drug Repositioning Business (2021-2026) & (US$ Million)

Table 70. Johnson & Johnson Recent Development

Table 71. Pfizer Company Details

Table 72. Pfizer Business Overview

Table 73. Pfizer Drug Repositioning Product

Table 74. Pfizer Revenue in Drug Repositioning Business (2021-2026) & (US$ Million)

Table 75. Pfizer Recent Development

Table 76. Bausch Health Company Details

Table 77. Bausch Health Business Overview

Table 78. Bausch Health Drug Repositioning Product

Table 79. Bausch Health Revenue in Drug Repositioning Business (2021-2026) & (US$ Million)

Table 80. Bausch Health Recent Development

Table 81. GSK Company Details

Table 82. GSK Business Overview

Table 83. GSK Drug Repositioning Product

Table 84. GSK Revenue in Drug Repositioning Business (2021-2026) & (US$ Million)

Table 85. GSK Recent Development

Table 86. ChemRar Group Company Details

Table 87. ChemRar Group Business Overview

Table 88. ChemRar Group Drug Repositioning Product

Table 89. ChemRar Group Revenue in Drug Repositioning Business (2021-2026) & (US$ Million)

Table 90. ChemRar Group Recent Development

Table 91. Glenmark Company Details

Table 92. Glenmark Business Overview

Table 93. Glenmark Drug Repositioning Product

Table 94. Glenmark Revenue in Drug Repositioning Business (2021-2026) & (US$ Million)

Table 95. Glenmark Recent Development

Table 96. Fujifilm Company Details

Table 97. Fujifilm Business Overview

Table 98. Fujifilm Drug Repositioning Product

Table 99. Fujifilm Revenue in Drug Repositioning Business (2021-2026) & (US$ Million)

Table 100. Fujifilm Recent Development

Table 101. Dr. Reddy Company Details

Table 102. Dr. Reddy Business Overview

Table 103. Dr. Reddy Drug Repositioning Product

Table 104. Dr. Reddy Revenue in Drug Repositioning Business (2021-2026) & (US$ Million)

Table 105. Dr. Reddy Recent Development

Table 106. R-Pharma Company Details

Table 107. R-Pharma Business Overview

Table 108. R-Pharma Drug Repositioning Product

Table 109. R-Pharma Revenue in Drug Repositioning Business (2021-2026) & (US$ Million)

Table 110. R-Pharma Recent Development

Table 111. Drug Repositioning Market Trends

Table 112. Drug Repositioning Market Drivers

Table 113. Drug Repositioning Market Challenges

Table 114. Drug Repositioning Market Restraints

Table 115. Research Programs/Design for This Report

Table 116. Key Data Information from Secondary Sources

Table 117. Key Data Information from Primary Sources

List of Figures

Figure 1. Drug Repositioning Product Picture

Figure 2. Global Drug Repositioning Market Share by Type: 2025 vs 2032

Figure 3. Generic Drugs Features

Figure 4. Clinical Trial Failed Drugs Features

Figure 5. Global Drug Repositioning Market Share by Application: 2025 vs 2032

Figure 6. Cardiovascular Diseases

Figure 7. Mental Illness

Figure 8. Cancer

Figure 9. Others

Figure 10. Drug Repositioning Report Years Considered

Figure 11. Global Drug Repositioning Market Size (US$ Million), Year-over-Year: 2021-2032

Figure 12. Global Drug Repositioning Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 13. Global Drug Repositioning Market Share by Revenue, by Region: 2021 vs 2025

Figure 14. North America Drug Repositioning Revenue (US$ Million) Growth Rate (2021-2032)

Figure 15. Europe Drug Repositioning Revenue (US$ Million) Growth Rate (2021-2032)

Figure 16. China Drug Repositioning Revenue (US$ Million) Growth Rate (2021-2032)

Figure 17. Japan Drug Repositioning Revenue (US$ Million) Growth Rate (2021-2032)

Figure 18. Southeast Aisa Drug Repositioning Revenue (US$ Million) Growth Rate (2021-2032)

Figure 19. India Drug Repositioning Revenue (US$ Million) Growth Rate (2021-2032)

Figure 20. Global Drug Repositioning Market Share by Players in 2025

Figure 21. Global Top Drug Repositioning Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Repositioning as of 2025)

Figure 22. The Top 10 and 5 Players Market Share by Drug Repositioning Revenue in 2025

Figure 23. North America Drug Repositioning Market Share by Type (2021-2026)

Figure 24. North America Drug Repositioning Market Share by Application (2021-2026)

Figure 25. Europe Drug Repositioning Market Share by Type (2021-2026)

Figure 26. Europe Drug Repositioning Market Share by Application (2021-2026)

Figure 27. China Drug Repositioning Market Share by Type (2021-2026)

Figure 28. China Drug Repositioning Market Share by Application (2021-2026)

Figure 29. Japan Drug Repositioning Market Share by Type (2021-2026)

Figure 30. Japan Drug Repositioning Market Share by Application (2021-2026)

Figure 31. Southeast Aisa Drug Repositioning Market Share by Type (2021-2026)

Figure 32. Southeast Aisa Drug Repositioning Market Share by Application (2021-2026)

Figure 33. India Drug Repositioning Market Share by Type (2021-2026)

Figure 34. India Drug Repositioning Market Share by Application (2021-2026)

Figure 35. Teva Revenue Growth Rate in Drug Repositioning Business (2021-2026)

Figure 36. Novartis Revenue Growth Rate in Drug Repositioning Business (2021-2026)

Figure 37. Mylan Revenue Growth Rate in Drug Repositioning Business (2021-2026)

Figure 38. Johnson & Johnson Revenue Growth Rate in Drug Repositioning Business (2021-2026)

Figure 39. Pfizer Revenue Growth Rate in Drug Repositioning Business (2021-2026)

Figure 40. Bausch Health Revenue Growth Rate in Drug Repositioning Business (2021-2026)

Figure 41. GSK Revenue Growth Rate in Drug Repositioning Business (2021-2026)

Figure 42. ChemRar Group Revenue Growth Rate in Drug Repositioning Business (2021-2026)

Figure 43. Glenmark Revenue Growth Rate in Drug Repositioning Business (2021-2026)

Figure 44. Fujifilm Revenue Growth Rate in Drug Repositioning Business (2021-2026)

Figure 45. Dr. Reddy Revenue Growth Rate in Drug Repositioning Business (2021-2026)

Figure 46. R-Pharma Revenue Growth Rate in Drug Repositioning Business (2021-2026)

Figure 47. Bottom-up and Top-down Approaches for This Report

Figure 48. Data Triangulation

Figure 49. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Drug Repositioning market? zhanKai

The top companies in the global Drug Repositioning market are Teva、Novartis、Mylan.

What was the global market size of Drug Repositioning in 2026? shouQi

Which region is expected to have the highest market share? shouQi

What is the annual compound growth rate of the global Drug Repositioning market size from 2026 to 2032? shouQi

What was the global market size of Drug Repositioning in 2032? shouQi

Related Reports

Global Drug Repositioning Market Research Report 2026
The global Drug Repositioning market was valued at US$ 30990 million in 2025 and is anticipated to reach US$ 42560 million by 2032, at a CAGR of 4.7% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 120
USD 2900.00
(Single User License)
Drug Repositioning - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Drug Repositioning was estimated to be worth US$ 30990 million in 2025 and is projected to reach US$ 42560 million, growing at a CAGR of 4.7% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 112
USD 3950.00
(Single User License)
Global Drug Repositioning Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Drug Repositioning market size was US$ 28780 million in 2024 and is forecast to a readjusted size of US$ 40830 million by 2031 with a CAGR of 4.7% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 96
USD 4250.00
(Single User License)
Global Drug Repositioning Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Drug Repositioning market is projected to grow from US$ 28780 million in 2024 to US$ 40830 million by 2031, at a CAGR of 4.7% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-08
Pages: 136
USD 4900.00
(Single User License)
Drug Repositioning - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Drug Repositioning was estimated to be worth US$ 28780 million in 2024 and is forecast to a readjusted size of US$ 40830 million by 2031 with a CAGR of 4.7% during the forecast period 2025-2031.
Published Date: 2025-04-16
Pages: 120
USD 3950.00
(Single User License)
Global Drug Repositioning Market Insights, Forecast to 2031
The global Drug Repositioning market is projected to grow from US$ 30990 million in 2025 to US$ 40830 million by 2031, at a Compound Annual Growth Rate (CAGR) of 4.7% during the forecast period.
Published Date: 2025-04-16
Pages: 136
USD 4900.00
(Single User License)
Global Drug Repositioning Market Research Report 2025
The global market for Drug Repositioning was valued at US$ 28780 million in the year 2024 and is projected to reach a revised size of US$ 40830 million by 2031, growing at a CAGR of 4.7% during the forecast period.
Published Date: 2025-04-16
Pages: 83
USD 2900.00
(Single User License)
Drug Repositioning- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Drug Repositioning was estimated to be worth US$ 28780 million in 2024 and is forecast to a readjusted size of US$ 39510 million by 2031 with a CAGR of 4.7% during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 103
USD 3950.00
(Single User License)
Global Drug Repositioning Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.
Published Date: 2024-04-17
Pages: 152
USD 5600.00
(Single User License)
Global Drug Repositioning Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.
Published Date: 2024-04-16
Pages: 153
USD 5900.00
(Single User License)

Global Drug Repositioning Market Research Report 2026
The global Drug Repositioning market was valued at US$ 30990 million in 2025 and is anticipated to reach US$ 42560 million by 2032, at a CAGR of 4.7% from 2026 to 2032.
Published: 2026-01-05
Pages: 120
USD 2900.00 (Single User License)
Drug Repositioning - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Drug Repositioning was estimated to be worth US$ 30990 million in 2025 and is projected to reach US$ 42560 million, growing at a CAGR of 4.7% from 2026 to 2032.
Published: 2026-01-05
Pages: 112
USD 3950.00 (Single User License)
Global Drug Repositioning Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Drug Repositioning market size was US$ 28780 million in 2024 and is forecast to a readjusted size of US$ 40830 million by 2031 with a CAGR of 4.7% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 96
USD 4250.00 (Single User License)
Global Drug Repositioning Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Drug Repositioning market is projected to grow from US$ 28780 million in 2024 to US$ 40830 million by 2031, at a CAGR of 4.7% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-08
Pages: 136
USD 4900.00 (Single User License)
Drug Repositioning - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Drug Repositioning was estimated to be worth US$ 28780 million in 2024 and is forecast to a readjusted size of US$ 40830 million by 2031 with a CAGR of 4.7% during the forecast period 2025-2031.
Published: 2025-04-16
Pages: 120
USD 3950.00 (Single User License)
Global Drug Repositioning Market Insights, Forecast to 2031
The global Drug Repositioning market is projected to grow from US$ 30990 million in 2025 to US$ 40830 million by 2031, at a Compound Annual Growth Rate (CAGR) of 4.7% during the forecast period.
Published: 2025-04-16
Pages: 136
USD 4900.00 (Single User License)
Global Drug Repositioning Market Research Report 2025
The global market for Drug Repositioning was valued at US$ 28780 million in the year 2024 and is projected to reach a revised size of US$ 40830 million by 2031, growing at a CAGR of 4.7% during the forecast period.
Published: 2025-04-16
Pages: 83
USD 2900.00 (Single User License)
Drug Repositioning- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Drug Repositioning was estimated to be worth US$ 28780 million in 2024 and is forecast to a readjusted size of US$ 39510 million by 2031 with a CAGR of 4.7% during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 103
USD 3950.00 (Single User License)
Global Drug Repositioning Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.
Published: 2024-04-17
Pages: 152
USD 5600.00 (Single User License)
Global Drug Repositioning Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.
Published: 2024-04-16
Pages: 153
USD 5900.00 (Single User License)